Form 4 for CME CME Group
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001628280-26-018540 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-15 | CME | Vroman Ken | Chief Transformation Off | A - Grant | $311.40 | +7,076 | 22.0K | +47% | +$2.20M | |
| 2026-03-17 | 2026-03-15 | CME | Vroman Ken | Chief Transformation Off | F - Tax | $311.40 | -3,135 | 18.9K | -14% | -$976.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2026-03-15 | A | A | 7,076 | $311.40 | 21,986 | D | — | — | (F1) Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. |
| 2 | Common | Common Stock Class A | 2026-03-15 | F | D | 3,135 | $311.40 | 18,851 | D | — | — | (F2) Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. |